Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
120.43
+4.72 (4.08%)
At close: May 12, 2025, 4:00 PM
118.51
-1.92 (-1.59%)
After-hours: May 12, 2025, 7:15 PM EDT
Neurocrine Biosciences (NBIX) Revenue by Segment
History
| Date | Ingrezza | Collaboration and Other | Ongentys and Other Products |
|---|---|---|---|
| Mar 31, 2025 | 2.35B | 27.30M | 18.20M |
| Dec 31, 2024 | 2.31B | 24.70M | 17.20M |
| Sep 30, 2024 | 2.20B | 26.20M | 18.00M |
| Jun 30, 2024 | 2.07B | 27.70M | 20.40M |
| Mar 31, 2024 | 1.93B | 27.70M | 22.70M |
| Dec 31, 2023 | 1.84B | 26.50M | 24.60M |
| Sep 30, 2023 | 1.74B | 25.90M | 23.00M |
| Jun 30, 2023 | 1.63B | 27.50M | 19.80M |
| Mar 31, 2023 | 1.54B | 47.30M | 15.60M |
| Dec 31, 2022 | 1.43B | 47.80M | 13.10M |
| Sep 30, 2022 | 1.33B | 48.90M | 10.20M |
| Jun 30, 2022 | 1.24B | 47.50M | 9.60M |
| Mar 31, 2022 | 1.15B | 43.40M | 9.20M |
| Dec 31, 2021 | 1.08B | 43.40M | 8.20M |
| Sep 30, 2021 | 1.02B | 41.50M | 6.60M |
| Jun 30, 2021 | 988.80M | 38.70M | 4.40M |
| Mar 31, 2021 | 991.60M | 51.40M | 2.40M |
| Dec 31, 2020 | 762.00M | 51.80M | 1.00M |
| Sep 30, 2020 | 521.60M | 51.40M | 100.00K |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.